[{"type": "title", "data": "SURG VTE Prophylaxis"}, {"type": "category", "data": "Medications"}, {"type": "note", "data": "VTE RISK IS MODERATE OR HIGH "}, {"type": "note", "data": "Epidural / perineural is contraindicated if enoxaparin dose exceeds 40 mg daily or dalteparin dose exceeds 5000 units daily or heparin doses exceeds 5000 units q8h or fondaparinux any dose or rivaroxaban any dose "}, {"type": "note", "data": "Low Molecular Weight Heparin "}, {"type": "note", "data": "enoxaparin for eGFR 30 mL/min or greater "}, {"type": "order", "data": "enoxaparin", "value": ""}, {"type": "sentence", "data": "40 mg, SubQ, PFS, qAM, T+1;1000, 180 day(s)"}, {"type": "sentence", "data": "30 mg, SubQ, PFS, qAM, T+1;1000, 180 day(s)"}, {"type": "sentence", "data": "40 mg, SubQ, PFS, q12hr, T+1;1000, 180 day(s)"}, {"type": "sentence", "data": "60 mg, SubQ, PFS, q12hr, T+1;1000, 180 day(s)"}, {"type": "note", "data": "enoxaparin for eGFR 10 to 29 mL/min "}, {"type": "order", "data": "enoxaparin", "value": ""}, {"type": "sentence", "data": "30 mg, SubQ, PFS, qAM, T+1;1000, 180 day(s)"}, {"type": "sentence", "data": "40 mg, SubQ, PFS, qAM, T+1;1000, 180 day(s)"}, {"type": "sentence", "data": "60 mg, SubQ, PFS, qAM, T+1;1000, 180 day(s)"}, {"type": "note", "data": "enoxaparin for patients with high risk poly-trauma / skeletal trauma. Contraindicated if epidural / perineural to be placed or in situ for neuraxial blockade "}, {"type": "order", "data": "enoxaparin", "value": ""}, {"type": "sentence", "data": "30 mg, SubQ, PFS, qAM, T+1;1000, 180 day(s)"}, {"type": "sentence", "data": "30 mg, SubQ, PFS, qHS, T+1;2200, 180 day(s)"}, {"type": "note", "data": "Unfractionated Heparin "}, {"type": "note", "data": "heparin for eGFR less than 10 mL/min or on dialysis "}, {"type": "order", "data": "heparin", "value": ""}, {"type": "sentence", "data": "2,500 unit(s), SubQ, Injection, q12hr(sched), T+1;1000, 180 day(s)"}, {"type": "sentence", "data": "2,500 unit(s), SubQ, Injection, q12hr(sched), T+1;2200, 180 day(s)"}, {"type": "sentence", "data": "5,000 unit(s), SubQ, Injection, q12hr(sched), T+1;1000, 180 day(s)"}, {"type": "sentence", "data": "5,000 unit(s), SubQ, Injection, q12hr(sched), T+1;2200, 180 day(s)"}, {"type": "sentence", "data": "5,000 unit(s), SubQ, Injection, q8hr, T+1;0600, 180 day(s)"}, {"type": "sentence", "data": "5,000 unit(s), SubQ, Injection, q8hr, T+1;2200, 180 day(s)"}, {"type": "note", "data": "heparin for patients with epidural / perineural catheter and weight 101 kg or greater and eGFR 30 mL/min or greater; or weight 141 kg or greater and eGFR less than 30 mL/min "}, {"type": "order", "data": "heparin", "value": ""}, {"type": "sentence", "data": "5,000 unit(s), SubQ, Injection, q8hr(sched), 180 day(s)"}, {"type": "note", "data": "High risk patients who need prophylaxis on post operative DAY ZERO. This is a one time dose "}, {"type": "order", "data": "heparin", "value": ""}, {"type": "sentence", "data": "5,000 unit(s), SubQ, Injection, Once, T;2200"}, {"type": "sentence", "data": "5,000 unit(s), SubQ, Injection, Once, T;1800"}, {"type": "sentence", "data": "5,000 unit(s), SubQ, Injection, Once, T;1900"}, {"type": "sentence", "data": "5,000 unit(s), SubQ, Injection, Once, T;2000"}, {"type": "sentence", "data": "5,000 unit(s), SubQ, Injection, Once, T;2100"}, {"type": "sentence", "data": "5,000 unit(s), SubQ, Injection, Once, T;2300"}, {"type": "note", "data": "Direct Oral Anticoagulant "}, {"type": "note", "data": "rivaroxaban restricted to post-hip or knee arthroplasty. Contraindicated if epidural / perineural to be placed or in situ or e-GFR is less than 30 mL/min. "}, {"type": "note", "data": "Total Knee Replacement "}, {"type": "order", "data": "rivaroxaban", "value": ""}, {"type": "sentence", "data": "10 mg, PO, Tab, breakfast, T+1;1000, 14 day(s)"}, {"type": "note", "data": "Total Hip Replacement "}, {"type": "order", "data": "rivaroxaban", "value": ""}, {"type": "sentence", "data": "10 mg, PO, Tab, breakfast, T+1;1000, 35 day(s)"}, {"type": "note", "data": "Antiplatelet "}, {"type": "note", "data": "ASA EC for post hip or knee surgery if on mechanical prophylaxis only "}, {"type": "order", "data": "ASA 81 mg oral delayed release tablet", "value": ""}, {"type": "sentence", "data": "162 mg, PO, EC Tablet, Daily, 180 day(s), with food"}, {"type": "note", "data": "VTE RISK IS MODERATE OR HIGH WITH CONTRAINDICATION TO ANTICOAGULANTS "}, {"type": "note", "data": "Mechanical Prophylaxis "}, {"type": "note", "data": "<P>Mechanical prophylaxis contraindicated in: </P><P>- Peripheral vascular disease with absent pedal pulses </P><P>- Severe peripheral neuropathy </P><P>- Skin breakdown, ulcers, gangrene, cellulitis, or dermatitis </P><P>- Skin grafting within last 3 months </P><P>- Allergy to stocking or compression cuff materials </P><P>- Unable to size or apply properly due to deformity, recent surgery or trauma </P><P>- Acute stroke with immobility (unable to walk independently to the toilet) should not use graduated compression stockings or calf-length / below the knee Sequential Compression Devices. Thigh-length / full length Sequential Compression Device should be utilized </P>"}, {"type": "order", "data": "Anti-embolism Stocking", "value": ""}, {"type": "sentence", "data": "T;N, Below the knees - apply continuously until anticoagulant prophylaxis starts or patient discharge. Interrupt for skin care, assessments, toileting, and ambulation only"}, {"type": "order", "data": "Sequential Compression Device (SCD) Application", "value": ""}, {"type": "sentence", "data": "T;N, Full legs - apply to lower limb(s) continuously until anticoagulant prophylaxis starts or discharge. Interrupt for skin care, assessments, toileting, and ambulation only"}, {"type": "order", "data": "Sequential Compression Device (SCD) Application", "value": ""}, {"type": "sentence", "data": "T;N, Below the knee - apply to lower limb(s) continuously until anticoagulant prophylaxis starts or discharge. Interrupt for skin care, assessments, toileting, and ambulation only"}, {"type": "order", "data": "Communication Order", "value": ""}, {"type": "sentence", "data": "T;N, No mechanical prophylaxis because of contraindication(s)"}, {"type": "note", "data": "For medical patients, refer to Venous Thromboembolism (VTE) Prophylaxis - Medicine (Module) "}, {"type": "note", "data": "For obstetrical patients, refer to OB Postpartum VTE Thromboprophylaxis (Module) "}, {"type": "note", "data": "Refer to VTE Risk Assessment and Thromboprophylaxis Recommendation "}, {"type": "note", "data": "<P>For patients receiving prophylactic subcutaneous enoxaparin up to 40 mg qdaily or dalteparin up to 5000 units qdaily or heparin up to 5000 units Q8H: </P><P>-Do not remove epidural/perineural catheter for at least 12 hours after the last dose of LMWH (enoxaparin or dalteparin) or at least 4 hours after the last dose of heparin </P><P>-After catheter removal, do not administer LMWH (enoxaparin or dalteparin) for at least 4 hours or heparin for at least 1 hour </P>"}, {"type": "note", "data": "<P>Order pharmacologic prophylaxis except when: </P><P>- Active bleeding of clinical significance requiring intervention </P><P>- High risk of serious bleeding or bleeding into a critical site (e.g. intracranial, epidural, pericardial, intraocular, retroperitoneal, intra-articular) </P><P>- Known major bleeding disorder or acquired coagulopathy (consider Hematology consult) </P><P>- Platelet count less than 50 x 10^9/L (consider Hematology consult) </P><P>- If history of Heparin-Induced Thrombocytopenia (HIT), DO NOT give LMWH or heparin. Consider fondaparinux (listed below) or consult Hematology / Internal Medicine for use of an alternative agent if eGFR less than 30mL/min </P><P>- Patient already receiving therapeutic anticoagulation </P>"}, {"type": "order", "data": "Communication Order", "value": ""}, {"type": "sentence", "data": "VTE Prophylaxis Contraindication: Active Bleeding Requiring Intervention"}, {"type": "sentence", "data": "VTE Prophylaxis Contraindication: Risk of Serious Bleed in Critical Site"}, {"type": "sentence", "data": "VTE Prophylaxis Contraindication: Known Major Bleed Disorder/Coagulopathy"}, {"type": "sentence", "data": "VTE Prophylaxis Contraindication: Platelet Count Less Than 50 x 10^9/L"}, {"type": "sentence", "data": "VTE Prophylaxis Contraindication: History of Heparin-Induced Thrombocytopenia, DO NOT give LMWH or heparin"}, {"type": "sentence", "data": "VTE Prophylaxis Contraindication: Receiving Therapeutic Anticoagulant"}, {"type": "note", "data": "For spinal surgery patients, recommended order first post-op dose 24 hours after admission to PACU "}, {"type": "note", "data": "VTE RISK IS LOW "}, {"type": "order", "data": "Ambulate", "value": ""}, {"type": "sentence", "data": "T;N, No anticoagulant or no mechanical prophylaxis required"}, {"type": "order", "data": "Communication Order", "value": ""}, {"type": "sentence", "data": "For spinal surgery patients, give first post-op VTE prophylaxis dose 24 hours after admission to PAC"}]
